|
1
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cory S and Adams JM: The Bcl-2 family:
regulators of the cellular life-of-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reed JC: Mechanisms of apoptosis. Am J
Pathol. 157:1415–1430. 2000. View Article : Google Scholar
|
|
4
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vaux DL and Korsmeyer SJ: Cell death in
development. Cell. 96:245–254. 1999. View Article : Google Scholar
|
|
6
|
Hsu YT, Wolter KG and Youle RJ:
Cytosol-to-membrane redistribution of Bax and Bcl-XL
during apoptosis. Proc Natl Acad Sci USA. 94:3668–3672. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wolter KG, Hsu YT, Smith CL, Nechushtan A,
Xi XG and Youle RJ: Movement of Bax from the cytosol to
mitochondria during apoptosis. J Cell Biol. 139:1281–1292. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Antonsson B, Montessuit S, Lauper S, Eskes
R and Martinou JC: Bax oligomerization is required for
channel-forming activity in liposomes and to trigger cytochrome
c release from mitochondria. Biochem J. 345:271–278. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jürgensmeier JM, Xie Z, Deveraux Q,
Ellerby L, Bredesen D and Reed JC: Bax directly induces release of
cytochrome c from isolated mitochondria. Proc Natl Acad Sci
USA. 95:4997–5002. 1998.PubMed/NCBI
|
|
10
|
Kluck RM, Bossy-Wetzel E, Green DR and
Newmeyer DD: The release of cytochrome c from mitochondria:
a primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136. 1997.PubMed/NCBI
|
|
11
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: release of cytochrome c from mitochondria blocked.
Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thomenius MJ, Wang NS, Reineks EZ, Wang Z
and Distelhorst CW: Bcl-2 on the endoplasmic reticulum regulates
Bax activity by binding to BH3-only proteins. J Biol Chem.
278:6243–6250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Antonsson B, Conti F, Ciavatta A,
Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod
JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R and Martinou JC:
Inhibition of Bax channel-forming activity by Bcl-2. Science.
277:370–372. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Youle RJ and Strasser A: The BCL-2 protein
family: opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kitada S, Pedersen IM, Schimmer AD and
Reed JC: Dysregulation of apoptosis genes in hematopoietic
malignancies. Oncogene. 21:3459–3474. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Newman DJ, Cragg GM and Snader KM: The
influence of natural products upon drug discovery. Nat Prod Rep.
17:215–234. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ju HK, Baek SH, An RB, Bae K, Son KH, Kim
HP, Kang SS, Lee SH, Son JK and Chang HW: Inhibitory effects of
nardostachin on nitric oxide, prostaglandin E2, and
tumor necrosis factor-α production in lipopolysaccharide activated
macrophages. Biol Pharm Bull. 26:1375–1378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiu LC, Ho TS, Wong EY and Ooi VE: Ethyl
acetate extract of Patrinia scabiosaefolia downregulates
anti-apoptotic Bcl-2/Bcl-XL expression, and induces
apoptosis in human breast carcinoma MCF-7 cells independent of
caspase-9 activation. J Ethnopharmacol. 105:263–268.
2006.PubMed/NCBI
|
|
21
|
Peng J, Chen YQ, Lin JM, Zhuang ZQ, Xu W,
Hong ZF and Sferra TJ: Patrinia scabiosaefolia extract
suppresses proliferation and promotes apoptosis by inhibiting STAT3
pathway in human multiple myeloma cells. Mol Med Rep. 4:313–318.
2011.
|
|
22
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
23
|
Gustin DM and Brenner DE: Chemoprevention
of colon cancer: current status and future prospects. Cancer
Metastasis Rev. 21:323–348. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gorlick R and Bertino JR: Drug resistance
in colon cancer. Semin Oncol. 26:606–611. 1999.
|
|
25
|
Longley DB, Allen WL and Johnston PG: Drug
resistance, predictive markers and pharmacogenomics in colorectal
cancer. Biochim Biophys Acta. 1766:184–196. 2006.PubMed/NCBI
|
|
26
|
Boose G and Stopper H: Genotoxicity of
several clinically used topoisomerase II inhibitors. Toxicol Lett.
116:7–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mäntymaa P, Siitonen T, Guttorm T, Säily
M, Kinnula V, Savolainen ER and Koistinen P: Induction of
mitochondrial manganese superoxide dismutase confers resistance to
apoptosis in acute myeloblastic leukaemia cells exposed to
etoposide. Br J Haematol. 108:574–581. 2000.PubMed/NCBI
|
|
28
|
Körper S, Nolte F, Rojewski MT, Thiel E
and Schrezenmeier H: The K+ channel openers diazoxide
and NS1619 induce depolarization of mitochondria and have
differential effects on cell Ca2+ in CD34+
cell line KG-1a. Exp Hematol. 31:815–823. 2003.
|
